BOSTON, MA — Caydan Capital Partners announced today that its portfolio company, MitoSense, Inc., has signed a Memorandum of Understanding (MOU) with the University of Pittsburgh to explore research opportunities at the intersection of mitochondrial biology, space biomedicine, and long COVID.
Plymouth, MA – Caydan Capital Partners announced today that its portfolio company, MitoSense Inc., a pioneering biotechnology company specializing in mitochondria-based therapeutics, has been granted a Japanese patent (Patent No. 7617652) for its innovative approach to treating neurodegenerative diseases, including Amyotrophic Lateral Sclerosis (ALS). This milestone underscores MitoSense’s...
Plymouth, MA – Caydan Capital Partners announced today that its portfolio company, MitoSense, Inc., a pioneering research and development company focused on treatments for neurodegenerative diseases, has been issued U.S. Patent No. 12,150,958, titled “Compositions and Methods for Treatment of Amyotrophic Lateral Sclerosis (ALS) and Other Neurodegenerative Diseases, and Associated Methods...
BOSTON, MA — Caydan Capital Partners today announced that it has led a $965,000 venture financing for TecTraum Inc., a medical device company developing pro2cool®, a first-of-its-kind point-of-care treatment platform for concussions.
BOSTON, MA — Caydan Capital Partners, a leading lower middle market private equity investment firm, announced the appointment of Naresh Shanker as Senior Advisor of Caydan Ventures, the investment firm’s early-stage venture arm. Mr. Shanker will serve as an executive resource for Caydan’s portfolio companies.
BOSTON, MA – Caydan Capital Partners announced today that it, together with Phoenix Merchant Partners, has provided $13 million in growth financing to HCT Renewable Energy (“HCT”), a leading solar industry staffing firm. The investment capital is intended to accelerate and optimize HCT’s growth in the solar energy staffing field.
PLYMOUTH, Mass., Jan. 22, 2024 /PRNewswire/—Caydan Capital Partners has led a Series Seed Funding Round for MitoSense Inc., a research and development company focused on treatments for neurodegenerative diseases. The round raised close to $3.5 million and will support MitoSense’s continued advancement of its proprietary Mitochondria Organelle Transplantation, or MOT™, technology...
BOSTON, MA — Caydan Capital Partners, a leading lower middle market private equity investment firm announced the appointment of Sam Waicberg as Managing Partner, Caydan Ventures. Mr. Waicberg brings extensive executive experience to Caydan and will have a broad mandate as Managing Partner—working with Caydan’s investment teams to...
BOSTON, MA—Asydan Capital Management, LLC, a leading lower middle market private equity firm based in Boston, Massachusetts, announced today its merger with Kestrel Merchant Partners, a respected merchant bank focused on small cap and special situations public equity. As part of the merger, Asydan will change its name to Caydan Capital Partners.
BOSTON, MA—Asydan* Capital Management, LLC (“Asydan”), a leading lower middle market private equity firm based in Boston, Massachusetts, announced today that it, along with Atalaya Capital Management LP (“Atalaya”), an alternative asset manager focused on private credit and special opportunities investments, has successfully exited its investment in The SAILS Group, Inc.
We target North American companies with strong management teams, profitable historical operating performance (generally $2M -$15M of EBITDA), and favorable market dynamics.
We invest in and partner with high-potential, early-stage companies—equipping them with the resources and expertise they need to overcome challenges, and fully harness their innovative spirit for success.